Stockreport

Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report

Alterity Therapeutics Limited - American Depositary Shares  (ATHE) 
PDF Highlights:European Commission designated Orphan Drug status for ATH434's treatment of Multiple System Atrophy in the European Union Phase 2 preparatory work continues C [Read more]